Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 2003-2011
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.2003
Table 1 Univariate analysis of the patients with different prognoses
Factor
Classify
Survival (n = 50)
Death (n = 10)
χ2
P value
SexMale34 (68.00)6 (60.00)0.2400.624
Female16 (32.00)4 (40.00)
Age> 60 yr21 (42.00)7 (70.00)2.6250.105
Admidia 60 yr29 (58.00)3 (30.00)
Bommann classificationI-II mold35 (70.00)4 (40.00)3.2970.069
III-IV mold15 (30.00)6 (60.00)
Histological typePoorly differentiated30 (60.00)1 (10.00)10.1410.006
Moderately differentiated11 (22.00)3 (30.00)
Well-differentiated9 (18.00)6 (60.00)
Tumor size≤ 5 cm38 (76.00)2 (20.00)11.760< 0.001
> 5 cm12 (24.00)8 (80.00)
TNM by stagesI-II designated time35 (70.00)1 (10.00)12.500< 0.001
III-IV designated time15 (30.00)9 (90.00)
Vascular invasionHave13 (26.00)6 (60.00)4.4520.035
Not have37 (74.00)4 (40.00)
Postoperative adjuvant chemoradiation therapyNot have16 (32.00)8 (80.00)8.0000.005
Have34 (68)2 (20)
Lymphatic metastasisHave10 (20)3 (30)0.4910.483
Not have40 (80)7 (70)